Deltagen Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2011. For the quarter, the company's revenues were $200,000. Loss from operations was $1,314,000. Loss before provision for income taxes was $1,314,000. Net loss was $1,314,000. Net cash flow operating activities was $597,000. The revenues in the fourth quarter and in 2011 were attributable to license fees associated with the provision of knockout mice and related phenotypic data pursuant to orders placed by customers under the company's DeltaOne(TM) program. For the year, the company's revenues were $902,000. Loss from operations was $2,846,000. Loss before provision for income taxes was $2,843,000. Net loss was $2,843,000. Net cash outflow from operating activities was $2,121,000.